AUS
NZ
UK
CA
USA
IND
Highlights
- Cardinal Health price target raised to $142.00.
- Quarterly earnings exceed expectations with $1.88 EPS.
- Institutional activity shows growth, with 87.17% of shares owned by major funds.
Cardinal Health Inc, a prominent name in NYSE Healthcare Stocks, has seen its price target raised to $142.00, reflecting strong market confidence. With robust quarterly earnings of $1.88 per share, steady dividend growth, and significant institutional activity, Cardinal Health continues to deliver tailored healthcare solutions globally, reinforcing its position as a leader in the healthcare services and products sector.
Consistent Stock Performance with Raised Price Target
Cardinal Health (NYSE:CAH) opened at $128.89 on Friday, trading near its 12-month high of $129.68. The company’s stock has a market capitalization of $31.19 billion, with a price-to-earnings ratio of 25.08 and a beta of 0.63, highlighting its relative stability in the healthcare services sector.
The company’s 50-day moving average of $121.36 and 200-day moving average of $113.16 reflect steady growth. With its price target now raised to $142.00, Cardinal Health demonstrates strong market confidence.
Earnings Beat Expectations with $1.88 EPS
In its recent quarterly report, Cardinal Health announced earnings of $1.88 per share, surpassing analyst estimates of $1.62 by $0.26. Despite a year-over-year revenue decrease of 4.3%, the company posted quarterly revenue of $52.28 billion, exceeding consensus expectations of $50.90 billion.
Cardinal Health achieved a net margin of 0.56% and continues to maintain operational efficiency, despite challenges in the healthcare services landscape. Analysts project an EPS of 7.82 for the current fiscal year, reflecting confidence in its ability to sustain strong performance.
Dividend Stability and Yield
Cardinal Health recently announced a quarterly dividend of $0.5056 per share, resulting in an annualized dividend of $2.02 and a yield of 1.57%. With a payout ratio of 39.30%, the company remains committed to delivering steady returns to shareholders. The ex-dividend date was January 2nd, and the payment was made on January 15th.
Institutional Engagement Strengthens Cardinal Health’s Market Position
Institutional investors hold 87.17% of Cardinal Health’s stock, signaling strong market confidence. Notable activity includes State Street Corp increasing holdings by 4.6% to 14.2 million shares, valued at over $1.5 billion. Geode Capital Management LLC raised its position by 0.7%, and Pacer Advisors Inc. expanded its stake by 4.7%. Charles Schwab Investment Management Inc. also increased holdings by 2.3%, highlighting widespread support for Cardinal Health’s operational performance.
Global Presence in Healthcare Solutions
Cardinal Health operates as a healthcare services and products company with a global footprint spanning the United States, Canada, Europe, Asia, and other international markets. The company offers customized solutions for hospitals, healthcare systems, pharmacies, clinical laboratories, ambulatory surgery centers, and physician offices.
Its focus on delivering tailored healthcare solutions has solidified its reputation as a leader in the healthcare services sector, addressing the diverse needs of healthcare providers and patients worldwide.
